Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Insights and Forecast to 2028

Report ID: 1228195 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Existing Drugs
        1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
        1.2.4 Aloxi (Palonosetron)
        1.2.5 Emend (Aprepitant)
        1.2.6 Kytril Generic (Granisetron)
        1.2.7 Zofran Generic (Ondansetron)
        1.2.8 Pipeline Drugs
        1.2.9 SUSTOL (Granisetron Injection extended release)
        1.2.10 Rolapitant
    1.3 Market by Application
        1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Serotonin Receptor Antagonists
        1.3.3 NK1 Receptor Antagonists
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region
        2.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
    2.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region
        2.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022)
        2.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturers
        3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs in 2021
    3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturers
        3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2021
    3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type
        4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type
        4.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type
        4.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022)
        4.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application
        5.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application
        5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application
        5.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022)
        5.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
        6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
        6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
    6.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
        6.2.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
        6.2.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
    6.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
        6.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
        6.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
        7.1.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
        7.1.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
    7.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
        7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
        7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
    7.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
        7.3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
        7.3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
        8.1.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
        8.2.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
        8.3.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
        9.1.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
    9.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
        9.2.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
    9.3 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
        9.3.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
        10.1.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
        10.2.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
        10.3.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck & Co., Inc.
        11.1.1 Merck & Co., Inc. Corporation Information
        11.1.2 Merck & Co., Inc. Overview
        11.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck & Co., Inc. Recent Developments
    11.2 GlaxoSmithKline plc
        11.2.1 GlaxoSmithKline plc Corporation Information
        11.2.2 GlaxoSmithKline plc Overview
        11.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline plc Recent Developments
    11.3 Tesaro, Inc.
        11.3.1 Tesaro, Inc. Corporation Information
        11.3.2 Tesaro, Inc. Overview
        11.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Tesaro, Inc. Recent Developments
    11.4 Helsinn Group
        11.4.1 Helsinn Group Corporation Information
        11.4.2 Helsinn Group Overview
        11.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Helsinn Group Recent Developments
    11.5 F. Hoffmann-La Roche Ltd.
        11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
        11.5.2 F. Hoffmann-La Roche Ltd. Overview
        11.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
    11.6 Heron Therapeutics, Inc.
        11.6.1 Heron Therapeutics, Inc. Corporation Information
        11.6.2 Heron Therapeutics, Inc. Overview
        11.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Heron Therapeutics, Inc. Recent Developments
    11.7 Dr. Reddy's Laboratories Ltd.
        11.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information
        11.7.2 Dr. Reddy's Laboratories Ltd. Overview
        11.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments
    11.8 Acacia Pharma
        11.8.1 Acacia Pharma Corporation Information
        11.8.2 Acacia Pharma Overview
        11.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Acacia Pharma Recent Developments
    11.9 Sun Pharmaceutical Industry Ltd.
        11.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
        11.9.2 Sun Pharmaceutical Industry Ltd. Overview
        11.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments
    11.10 Otsuka Holdings Co., Ltd.
        11.10.1 Otsuka Holdings Co., Ltd. Corporation Information
        11.10.2 Otsuka Holdings Co., Ltd. Overview
        11.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Otsuka Holdings Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Analysis
    12.2 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Chemotherapy-Induced Nausea and Vomiting Drugs Production Mode & Process
    12.4 Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Marketing
        12.4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channels
        12.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
    12.5 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
    13.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
    13.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
    13.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
14 Key Findings in The Global Chemotherapy-Induced Nausea and Vomiting Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Existing Drugs
    Table 3. Major Manufacturers of Akynzeo (Netupitant-Palonosetron FDC)
    Table 4. Major Manufacturers of Aloxi (Palonosetron)
    Table 5. Major Manufacturers of Emend (Aprepitant)
    Table 6. Major Manufacturers of Kytril Generic (Granisetron)
    Table 7. Major Manufacturers of Zofran Generic (Ondansetron)
    Table 8. Major Manufacturers of Pipeline Drugs
    Table 9. Major Manufacturers of SUSTOL (Granisetron Injection extended release)
    Table 10. Major Manufacturers of Rolapitant
    Table 11. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022) & (K Units)
    Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)
    Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2023-2028) & (K Units)
    Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2023-2028)
    Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2017-2022)
    Table 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2023-2028)
    Table 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturers (2017-2022)
    Table 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2017-2022)
    Table 25. Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2021)
    Table 28. Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Offered
    Table 30. Date of Manufacturers Enter into Chemotherapy-Induced Nausea and Vomiting Drugs Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 33. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2017-2022)
    Table 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2023-2028)
    Table 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2017-2022)
    Table 39. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2023-2028)
    Table 40. Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 41. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 42. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 43. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 44. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2017-2022)
    Table 45. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Application (2023-2028)
    Table 46. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2017-2022)
    Table 49. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2023-2028)
    Table 50. Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 51. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 52. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 53. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 54. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 55. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 56. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 57. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 58. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
    Table 61. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2023-2028) & (K Units)
    Table 62. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 65. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 66. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 67. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 68. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 69. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 70. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
    Table 73. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2023-2028) & (K Units)
    Table 74. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 77. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 78. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 81. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 82. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2017-2022) & (K Units)
    Table 85. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2023-2028) & (K Units)
    Table 86. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 89. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 90. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 93. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 94. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
    Table 97. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2023-2028) & (K Units)
    Table 98. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2022) & (K Units)
    Table 101. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2023-2028) & (K Units)
    Table 102. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2022) & (K Units)
    Table 105. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2023-2028) & (K Units)
    Table 106. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2017-2022) & (K Units)
    Table 109. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2023-2028) & (K Units)
    Table 110. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Merck & Co., Inc. Corporation Information
    Table 113. Merck & Co., Inc. Description and Major Businesses
    Table 114. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Merck & Co., Inc. Recent Developments
    Table 117. GlaxoSmithKline plc Corporation Information
    Table 118. GlaxoSmithKline plc Description and Major Businesses
    Table 119. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. GlaxoSmithKline plc Recent Developments
    Table 122. Tesaro, Inc. Corporation Information
    Table 123. Tesaro, Inc. Description and Major Businesses
    Table 124. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Tesaro, Inc. Recent Developments
    Table 127. Helsinn Group Corporation Information
    Table 128. Helsinn Group Description and Major Businesses
    Table 129. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Helsinn Group Recent Developments
    Table 132. F. Hoffmann-La Roche Ltd. Corporation Information
    Table 133. F. Hoffmann-La Roche Ltd. Description and Major Businesses
    Table 134. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 137. Heron Therapeutics, Inc. Corporation Information
    Table 138. Heron Therapeutics, Inc. Description and Major Businesses
    Table 139. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Heron Therapeutics, Inc. Recent Developments
    Table 142. Dr. Reddy's Laboratories Ltd. Corporation Information
    Table 143. Dr. Reddy's Laboratories Ltd. Description and Major Businesses
    Table 144. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Dr. Reddy's Laboratories Ltd. Recent Developments
    Table 147. Acacia Pharma Corporation Information
    Table 148. Acacia Pharma Description and Major Businesses
    Table 149. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Acacia Pharma Recent Developments
    Table 152. Sun Pharmaceutical Industry Ltd. Corporation Information
    Table 153. Sun Pharmaceutical Industry Ltd. Description and Major Businesses
    Table 154. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Sun Pharmaceutical Industry Ltd. Recent Developments
    Table 157. Otsuka Holdings Co., Ltd. Corporation Information
    Table 158. Otsuka Holdings Co., Ltd. Description and Major Businesses
    Table 159. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Otsuka Holdings Co., Ltd. Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
    Table 165. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
    Table 166. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
    Table 167. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
    Table 168. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
    Table 169. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Product Picture
    Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2021 & 2028
    Figure 3. Existing Drugs Product Picture
    Figure 4. Akynzeo (Netupitant-Palonosetron FDC) Product Picture
    Figure 5. Aloxi (Palonosetron) Product Picture
    Figure 6. Emend (Aprepitant) Product Picture
    Figure 7. Kytril Generic (Granisetron) Product Picture
    Figure 8. Zofran Generic (Ondansetron) Product Picture
    Figure 9. Pipeline Drugs Product Picture
    Figure 10. SUSTOL (Granisetron Injection extended release) Product Picture
    Figure 11. Rolapitant Product Picture
    Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2021 & 2028
    Figure 13. Serotonin Receptor Antagonists
    Figure 14. NK1 Receptor Antagonists
    Figure 15. Chemotherapy-Induced Nausea and Vomiting Drugs Report Years Considered
    Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028 (K Units)
    Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2028 (US$ Million)
    Figure 19. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2017-2022)
    Figure 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2023-2028)
    Figure 22. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales YoY (2017-2028) & (K Units)
    Figure 29. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales YoY (2017-2028) & (K Units)
    Figure 31. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs in the World: Market Share by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2021
    Figure 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 40. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 41. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 42. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 43. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Country (2017-2028)
    Figure 44. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Country (2017-2028)
    Figure 45. U.S. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 48. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 50. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Country (2017-2028)
    Figure 52. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Country (2017-2028)
    Figure 53. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2017-2028)
    Figure 64. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Country (2017-2028)
    Figure 79. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Country (2017-2028)
    Figure 80. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Country (2017-2028)
    Figure 89. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 91. U.A.E Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2017-2028) & (US$ Million)
    Figure 92. Chemotherapy-Induced Nausea and Vomiting Drugs Value Chain
    Figure 93. Chemotherapy-Induced Nausea and Vomiting Drugs Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Frequently Asked Questions
Chemotherapy-Induced Nausea and Vomiting Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chemotherapy-Induced Nausea and Vomiting Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chemotherapy-Induced Nausea and Vomiting Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cyprosin

Cyprosin market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More

Zellerite

Zellerite market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More

Wooden Crates

Wooden Crates market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More